Acid-base and electrolyte disorders associated with the use of antidiabetic drugs
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acid-base and electrolyte disorders associated with the use of antidiabetic drugs
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 16, Issue 10, Pages 1121-1132
Publisher
Informa UK Limited
Online
2017-07-27
DOI
10.1080/14740338.2017.1361400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Approach to the Treatment of Diabetic Ketoacidosis
- (2016) Kamel S. Kamel et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
- (2016) Ronald M. Goldenberg et al. CLINICAL THERAPEUTICS
- The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus
- (2016) Maria Alba et al. CURRENT MEDICAL RESEARCH AND OPINION
- Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
- (2016) Ele Ferrannini et al. DIABETES
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Diabetic Ketoacidosis Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
- (2016) Huilin Tang et al. DIABETES CARE
- SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
- (2016) Muhammad Abdul-Ghani et al. DIABETES CARE
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Could metformin be used in patients with diabetes and advanced chronic kidney disease?
- (2016) Tahseen A. Chowdhury et al. DIABETES OBESITY & METABOLISM
- Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials
- (2016) H. L. Tang et al. DIABETES OBESITY & METABOLISM
- Effect of acute hyperinsulinemia on magnesium homeostasis in humans
- (2016) Li Hao Richie Xu et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials
- (2016) Huilin Tang et al. DIABETOLOGIA
- Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
- (2016) Nikolaus Marx et al. EUROPEAN HEART JOURNAL
- Determinants of hypomagnesemia in patients with type 2 diabetes mellitus
- (2016) Steef Kurstjens et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment
- (2016) G Liamis et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Ten common pitfalls in the evaluation of patients with hyponatremia
- (2016) T.D. Filippatos et al. European Journal of Internal Medicine
- Electrolyte disorders associated with the use of anticancer drugs
- (2016) George Liamis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- (2016) T. D. Filippatos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise
- (2016) G. Liamis et al. Hepatology International
- Nephroprotective Effects of Metformin in Diabetic Nephropathy
- (2016) Sreenithya Ravindran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin
- (2016) John P. Bilezikian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
- (2016) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney
- (2016) Biff F. Palmer et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Metformin associated lactic acidosis (MALA): clinical profiling and management
- (2016) Alessandra Moioli et al. JOURNAL OF NEPHROLOGY
- Importance of inhibiting sodium-glucose cotransporter and its compelling indication in type 2 diabetes: pathophysiological hypothesis
- (2016) Genjiro Kimura Journal of the American Society of Hypertension
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ten pitfalls in the proper management of patients with hyponatremia
- (2016) Theodosios D. Filippatos et al. POSTGRADUATE MEDICINE
- Metformin-related lactic acidosis: is it a myth or an underestimated reality?
- (2016) Luca Visconti et al. RENAL FAILURE
- Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?
- (2016) Damien Sémely et al. THERAPIE
- Pitavastatin and carbohydrate metabolism: what is the evidence?
- (2016) T. D. Filippatos et al. Expert Review of Clinical Pharmacology
- Pharmacological management of diabetic dyslipidemia
- (2016) T. D. Filippatos et al. Expert Review of Clinical Pharmacology
- Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health
- (2016) Andrea Egger et al. Current Osteoporosis Reports
- Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
- (2016) Yshai Yavin et al. Diabetes Therapy
- Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
- (2016) Yshai Yavin et al. Diabetes Therapy
- Statin–Ezetimibe Combination Therapy In Diabetic Individuals
- (2015) Theodosios D. Filippatos et al. ANGIOLOGY
- Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
- (2015) Ngozi Erondu et al. DIABETES CARE
- Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Anne L. Peters et al. DIABETES CARE
- Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
- (2015) Julio Rosenstock et al. DIABETES CARE
- Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)
- (2015) T. R. Pieber et al. DIABETES OBESITY & METABOLISM
- Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes
- (2015) B. Bode et al. DIABETES OBESITY & METABOLISM
- Safety considerations with fenofibrate/simvastatin combination
- (2015) Theodosios D Filippatos et al. Expert Opinion On Drug Safety
- SGLT2 Inhibitors May Predispose to Ketoacidosis
- (2015) Simeon I. Taylor et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
- (2015) Caroline Bonner et al. NATURE MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet
- (2015) Tomohide Hayami et al. Journal of Diabetes Investigation
- Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis
- (2015) Zachary T. Bloomgarden Journal of Diabetes
- Possible adverse effects of SGLT2 inhibitors on bone
- (2015) Simeon I Taylor et al. Lancet Diabetes & Endocrinology
- Role of NHE1 in the Cellular Dysfunction of Acute Metabolic Acidosis
- (2014) Dongmei Wu et al. AMERICAN JOURNAL OF NEPHROLOGY
- Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs
- (2014) L. H. Opie CARDIOVASCULAR DRUGS AND THERAPY
- Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR)
- (2014) Matthew R. Weir et al. CURRENT MEDICAL RESEARCH AND OPINION
- Incidence of Lactic Acidosis in Patients With Type 2 Diabetes With and Without Renal Impairment Treated With Metformin: A Retrospective Cohort Study
- (2014) Florent F. Richy et al. DIABETES CARE
- Risk of Lactic Acidosis or Elevated Lactate Concentrations in Metformin Users With Renal Impairment: A Population-Based Cohort Study
- (2014) Willemijn L. Eppenga et al. DIABETES CARE
- Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease
- (2014) J.-F. Yale et al. DIABETES OBESITY & METABOLISM
- The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors
- (2014) Theodosios D Filippatos et al. Expert Opinion on Drug Metabolism & Toxicology
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
- (2014) Ele Ferrannini et al. JOURNAL OF CLINICAL INVESTIGATION
- Ketone body metabolism and its defects
- (2014) Toshiyuki Fukao et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Management of adult diabetic ketoacidosis
- (2014) Aidar R Gosmanov et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Diabetes mellitus and electrolyte disorders
- (2014) George Liamis World Journal of Clinical Cases
- Electrolyte Disorders in Community Subjects: Prevalence and Risk Factors
- (2013) George Liamis et al. AMERICAN JOURNAL OF MEDICINE
- Spurious Electrolyte Disorders: A Diagnostic Challenge for Clinicians
- (2013) George Liamis et al. AMERICAN JOURNAL OF NEPHROLOGY
- Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs
- (2013) S. A. Al-Abri et al. CLINICAL TOXICOLOGY
- Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy
- (2013) S. Vecchio et al. CLINICAL TOXICOLOGY
- Hypokalemia during Treatment of Diabetic Ketoacidosis: Clinical Evidence for an Aldosterone-Like Action of Insulin
- (2013) Ana Paula de Carvalho Panzeri Carlotti et al. JOURNAL OF PEDIATRICS
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Relationship between Hypomagnesemia, Metformin Therapy and Cardiovascular Disease Complicating Type 2 Diabetes: The Fremantle Diabetes Study
- (2013) Kirsten E. Peters et al. PLoS One
- Approach to Treatment of Hypophosphatemia
- (2012) Arnold J. Felsenfeld et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
- (2012) Ö. Ljunggren et al. DIABETES OBESITY & METABOLISM
- Metformin in patients with chronic kidney disease: strengths and weaknesses
- (2012) Ana Rocha et al. JOURNAL OF NEPHROLOGY
- Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy
- (2012) A. V. Nair et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevalence of hypokalemia in ED patients with diabetic ketoacidosis
- (2011) Sanjay Arora et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia
- (2011) Theodosios D Filippatos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clinical Profile of Diabetic Ketoacidosis in Indian Children
- (2011) Sandeep Kumar Kanwal et al. INDIAN JOURNAL OF PEDIATRICS
- Hyponatremia in patients with infectious diseases
- (2011) George Liamis et al. JOURNAL OF INFECTION
- Use of Metformin in Patients with Kidney and Cardiovascular Diseases
- (2011) David Klachko et al. CardioRenal Medicine
- Influence of Therapy with Metformin on the Concentration of Certain Divalent Cations in Patients with Non-insulin-Dependent Diabetes Mellitus
- (2010) Monica Daniela Doşa et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Combination of Fenofibrate with Non-Statin Drug Regimens
- (2010) A. P. Agouridis et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
- (2010) Arpita Chakraborty et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pharmacologically-Induced Metabolic Acidosis
- (2010) George Liamis et al. DRUG SAFETY
- Lactic Acidosis Induced by Metformin
- (2010) Jean-Daniel Lalau DRUG SAFETY
- Medication-induced hypophosphatemia: a review
- (2010) G. Liamis et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Comparison of potential risks of lactic acidosis induction by biguanides in rats
- (2010) Kiyoko Bando et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
- (2009) Adriaan Kooy et al. ARCHIVES OF INTERNAL MEDICINE
- A Review of Drug-Induced Hyponatremia
- (2008) George Liamis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Ketoacidosis occurs in both Type1 and Type2 diabetes a population-based study from Northern Sweden
- (2008) Z. H. Wang et al. DIABETIC MEDICINE
- Treatment of hyperlipidaemia with fenofibrate and related fibrates
- (2008) Theodosios Filippatos et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Blood pressure drug therapy and electrolyte disturbances
- (2008) G. Liamis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Occult Metformin Toxicity in Three Patients with Profound Lactic Acidosis
- (2008) Jeanmarie Perrone et al. JOURNAL OF EMERGENCY MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started